Skip to content

Baxter International BAX Granted (in shares)

Granted (in shares) at other companies

Medline, Inc.
 logo
Medline, Inc. MDLN
0
Henry Schein logo
Henry ScheinHSIC
177.1K

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.

The official record: Baxter International’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's granted (in shares)?
Baxter International (BAX) reported granted (in shares) of 1.3M in Q4 2025.
What does granted (in shares) mean?
The number of stock-based awards given to employees during the period.
How do you interpret granted (in shares)?
High levels of grants may indicate aggressive talent retention strategies or dilution, while low levels may suggest cost-cutting or changes in compensation structure.
How does granted (in shares) compare across companies?
Standard disclosure for all public companies with equity incentive plans.